Drug-prescribing pattern in chronic kidney disease patients on maintenance haemodialysis and audit of cardiovascular complications in them: Pilot study from a tertiary care hospital

Introduction: The most frequent cause of morbidity in India is cardiovascular diseases (CVDs) complicating chronic kidney disease (CKD). Reports suggest that CKD patients with cardiovascular comorbidities are on multiple drugs, which could potentially lead to drug–drug interactions. This study inten...

Full description

Bibliographic Details
Main Authors: Vikram Raja, Princy Louis Palatty, Simon Sajan, Soniya Abraham, Thomas George, Prajna D'Silva, Manjeshwar Shrinath Baliga
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Hamdan Medical Journal
Subjects:
Online Access:http://www.hamdanjournal.org/article.asp?issn=2227-2437;year=2020;volume=13;issue=2;spage=88;epage=92;aulast=Raja
id doaj-47ab909db88e4ce7970e0024c24c32c2
record_format Article
spelling doaj-47ab909db88e4ce7970e0024c24c32c22020-12-02T12:48:24ZengWolters Kluwer Medknow PublicationsHamdan Medical Journal2227-24372227-247X2020-01-01132889210.4103/HMJ.HMJ_61_19Drug-prescribing pattern in chronic kidney disease patients on maintenance haemodialysis and audit of cardiovascular complications in them: Pilot study from a tertiary care hospitalVikram RajaPrincy Louis PalattySimon SajanSoniya AbrahamThomas GeorgePrajna D'SilvaManjeshwar Shrinath BaligaIntroduction: The most frequent cause of morbidity in India is cardiovascular diseases (CVDs) complicating chronic kidney disease (CKD). Reports suggest that CKD patients with cardiovascular comorbidities are on multiple drugs, which could potentially lead to drug–drug interactions. This study intends to describe the prevalent trends in prescribing drugs for the haemodialysed CKD patients and attempts to explore the cardiovascular complications and the factors influencing them. Methodology: This observational study was conducted on CKD patients on haemodialysis, presenting to the Dialysis Centre of Father Muller Medical College, Mangalore, Karnataka, India. The study recruited a total of 107 patients from whom data were collected at the first visit and at the end of 6 months. Results: Out of the 107 patients on haemodialysis, 38 cases of cardiovascular comorbidities were noted. Hyperkalaemia was observed in 32.4%, hypokalaemia in 10.5% and normal potassium levels in 56.8% of the patients with cardiovascular comorbidities. Hyperphosphataemia was observed in 65.6%, hypophosphatemia in 0.9% and normal serum phosphate in 33.3% of the patients with anaemia. Conclusions: CVDs are common in CKD patients, and concomitant anaemia and hyperglycaemia tend to complicate the management. In such a background, appropriate care has to be exercised in the treatment of CKD.http://www.hamdanjournal.org/article.asp?issn=2227-2437;year=2020;volume=13;issue=2;spage=88;epage=92;aulast=Rajaanaemiacardiovascular diseaseschronic kidney diseasedrug-prescribing trendsdrug–drug interactionshyperglycaemia
collection DOAJ
language English
format Article
sources DOAJ
author Vikram Raja
Princy Louis Palatty
Simon Sajan
Soniya Abraham
Thomas George
Prajna D'Silva
Manjeshwar Shrinath Baliga
spellingShingle Vikram Raja
Princy Louis Palatty
Simon Sajan
Soniya Abraham
Thomas George
Prajna D'Silva
Manjeshwar Shrinath Baliga
Drug-prescribing pattern in chronic kidney disease patients on maintenance haemodialysis and audit of cardiovascular complications in them: Pilot study from a tertiary care hospital
Hamdan Medical Journal
anaemia
cardiovascular diseases
chronic kidney disease
drug-prescribing trends
drug–drug interactions
hyperglycaemia
author_facet Vikram Raja
Princy Louis Palatty
Simon Sajan
Soniya Abraham
Thomas George
Prajna D'Silva
Manjeshwar Shrinath Baliga
author_sort Vikram Raja
title Drug-prescribing pattern in chronic kidney disease patients on maintenance haemodialysis and audit of cardiovascular complications in them: Pilot study from a tertiary care hospital
title_short Drug-prescribing pattern in chronic kidney disease patients on maintenance haemodialysis and audit of cardiovascular complications in them: Pilot study from a tertiary care hospital
title_full Drug-prescribing pattern in chronic kidney disease patients on maintenance haemodialysis and audit of cardiovascular complications in them: Pilot study from a tertiary care hospital
title_fullStr Drug-prescribing pattern in chronic kidney disease patients on maintenance haemodialysis and audit of cardiovascular complications in them: Pilot study from a tertiary care hospital
title_full_unstemmed Drug-prescribing pattern in chronic kidney disease patients on maintenance haemodialysis and audit of cardiovascular complications in them: Pilot study from a tertiary care hospital
title_sort drug-prescribing pattern in chronic kidney disease patients on maintenance haemodialysis and audit of cardiovascular complications in them: pilot study from a tertiary care hospital
publisher Wolters Kluwer Medknow Publications
series Hamdan Medical Journal
issn 2227-2437
2227-247X
publishDate 2020-01-01
description Introduction: The most frequent cause of morbidity in India is cardiovascular diseases (CVDs) complicating chronic kidney disease (CKD). Reports suggest that CKD patients with cardiovascular comorbidities are on multiple drugs, which could potentially lead to drug–drug interactions. This study intends to describe the prevalent trends in prescribing drugs for the haemodialysed CKD patients and attempts to explore the cardiovascular complications and the factors influencing them. Methodology: This observational study was conducted on CKD patients on haemodialysis, presenting to the Dialysis Centre of Father Muller Medical College, Mangalore, Karnataka, India. The study recruited a total of 107 patients from whom data were collected at the first visit and at the end of 6 months. Results: Out of the 107 patients on haemodialysis, 38 cases of cardiovascular comorbidities were noted. Hyperkalaemia was observed in 32.4%, hypokalaemia in 10.5% and normal potassium levels in 56.8% of the patients with cardiovascular comorbidities. Hyperphosphataemia was observed in 65.6%, hypophosphatemia in 0.9% and normal serum phosphate in 33.3% of the patients with anaemia. Conclusions: CVDs are common in CKD patients, and concomitant anaemia and hyperglycaemia tend to complicate the management. In such a background, appropriate care has to be exercised in the treatment of CKD.
topic anaemia
cardiovascular diseases
chronic kidney disease
drug-prescribing trends
drug–drug interactions
hyperglycaemia
url http://www.hamdanjournal.org/article.asp?issn=2227-2437;year=2020;volume=13;issue=2;spage=88;epage=92;aulast=Raja
work_keys_str_mv AT vikramraja drugprescribingpatterninchronickidneydiseasepatientsonmaintenancehaemodialysisandauditofcardiovascularcomplicationsinthempilotstudyfromatertiarycarehospital
AT princylouispalatty drugprescribingpatterninchronickidneydiseasepatientsonmaintenancehaemodialysisandauditofcardiovascularcomplicationsinthempilotstudyfromatertiarycarehospital
AT simonsajan drugprescribingpatterninchronickidneydiseasepatientsonmaintenancehaemodialysisandauditofcardiovascularcomplicationsinthempilotstudyfromatertiarycarehospital
AT soniyaabraham drugprescribingpatterninchronickidneydiseasepatientsonmaintenancehaemodialysisandauditofcardiovascularcomplicationsinthempilotstudyfromatertiarycarehospital
AT thomasgeorge drugprescribingpatterninchronickidneydiseasepatientsonmaintenancehaemodialysisandauditofcardiovascularcomplicationsinthempilotstudyfromatertiarycarehospital
AT prajnadsilva drugprescribingpatterninchronickidneydiseasepatientsonmaintenancehaemodialysisandauditofcardiovascularcomplicationsinthempilotstudyfromatertiarycarehospital
AT manjeshwarshrinathbaliga drugprescribingpatterninchronickidneydiseasepatientsonmaintenancehaemodialysisandauditofcardiovascularcomplicationsinthempilotstudyfromatertiarycarehospital
_version_ 1724406526188191744